Potential Benefits of Low-Dose GLP-1 Blockers While research is still early, clinicians are exploring this therapy for individuals dealing with: Chronic low-grade inflammation Fatigue, joint stiffness, and inflammatory markers that remain elevated even with lifestyle interventions
Nadanaka, S., Okada, T., Yoshida, H
However, it's important to note that the study was sponsored by a sublingual GSH company ( 6 )
In chronic wounds, there is excessive secretion of inflammatory mediators, such as cytokines and matrix metalloproteinases (MMPs), which degrade growth factors and the extracellular matrix (ECM), further impairing healing
Who Benefits from Peptide Therapy
This correlation was lost upon reoxygenation, however, as the NADP pool was rapidly reduced, while both Grx1-roGFP2 and roGFP2-Orp1 reported a burst in oxidation (Fig